IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma

Dual or multi-targets therapy targeting epidermal growth factor receptor variant III (EGFRvIII) and other molecular may relax the constraint for glioblastoma (GBM), putting forward the urgent requirement of finding candidate molecules. Here, the insulin-like growth factor binding protein-3 (IGFBP3)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuehua, Wang, Guoyan, Gong, Yujiao, Zhao, Leilei, Song, Ping, Zhang, He, Zhang, Yurui, Ju, Huanyu, Wang, Xiaoyu, Wang, Bin, Ren, Huan, Zhu, Xiao, Dong, Yucui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182331/
https://www.ncbi.nlm.nih.gov/pubmed/37192967
http://dx.doi.org/10.1016/j.isci.2023.106639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182331/
https://www.ncbi.nlm.nih.gov/pubmed/37192967
http://dx.doi.org/10.1016/j.isci.2023.106639

Ejemplares similares